Bill on Bankruptcy: AMR Make-Whole Opinion Vulnerable on Appeal
Last week, Democrat and Republican leaders of both houses of Congress agreed to the terms of a bill that would give the U.S. Food and Drug Administration (FDA) greater authority to regulate drug compounding and would revamp...more